Skip to main content

Lund University Publications

LUND UNIVERSITY LIBRARIES

Gene and pathway analysis of genome-wide genetic associations of bladder cancer

Shi, Mingjun ; Meng, Xiangyu ; Xu, Xuan and Wang, Qiaoli LU orcid (2025) In Current Urology 19(5). p.321-330
Abstract

Background Although genetic variants associated with bladder cancer (BCa) risk have been identified through hypothesis-driven and genome-wide association studies, a systematic understanding of BCa genetic susceptibility at the gene and pathway levels remains to be achieved. Materials and methods In this 2-stage functional genomics study, we used 5 independent tools for genome-wide gene mapping and ranking based on BCa genome-wide association studies summary statistics, followed by a meta-analysis of gene-level significance p values, to obtain a consensus gene ranking in terms of association with BCa. Subsequently, we performed preranked gene-set enrichment analysis to identify the functional pathways involved in BCa genetic... (More)

Background Although genetic variants associated with bladder cancer (BCa) risk have been identified through hypothesis-driven and genome-wide association studies, a systematic understanding of BCa genetic susceptibility at the gene and pathway levels remains to be achieved. Materials and methods In this 2-stage functional genomics study, we used 5 independent tools for genome-wide gene mapping and ranking based on BCa genome-wide association studies summary statistics, followed by a meta-analysis of gene-level significance p values, to obtain a consensus gene ranking in terms of association with BCa. Subsequently, we performed preranked gene-set enrichment analysis to identify the functional pathways involved in BCa genetic susceptibility. Joint analysis with gene-set enrichment analysis, based on somatic alteration frequency, was performed to explore the pathway-level relationships between genetic susceptibility and somatic alterations in BCa. Results Other than the well-known BCa genes (such as FGFR3, MYC, TERT, CCNE1, and TP63), we additionally prioritized a set of novel genes likely to be genetically implicated in BCa development, including SETD2, a possible tumor suppressor gene involved in chromatin remodeling. We further demonstrated convergence between genetic associations and somatic alterations at both the gene (eg, FGFR3 and TERT) and pathway levels (eg, cell cycle and chromatin modification), as well as functional ontologies specifically implicated in germline predisposition to BCa (eg, CD8/TCR signaling, immune checkpoints, and cytokine signaling). Conclusions We identified several novel genes associated with BCa and demonstrated that genetic variants contribute to the development of BCa by affecting antitumor immunity, response to toxic exposure, and RNA and protein homeostasis and synergizing with somatic alterations in various cancer-related pathways.

(Less)
Please use this url to cite or link to this publication:
author
; ; and
publishing date
type
Contribution to journal
publication status
published
subject
keywords
Bladder cancer, Functional annotation, Genetic susceptibility, Genome-wide association studies, Pathway analysis
in
Current Urology
volume
19
issue
5
pages
321 - 330
publisher
Lippincott Williams & Wilkins
external identifiers
  • scopus:105007843772
  • pmid:40894278
ISSN
1661-7649
DOI
10.1097/CU9.0000000000000289
language
English
LU publication?
no
additional info
Publisher Copyright: © Wolters Kluwer Health, Inc. All rights reserved.
id
c045a0ab-f0bd-41a3-8f36-248bae3c8e41
date added to LUP
2025-10-03 14:36:26
date last changed
2025-10-04 14:01:45
@article{c045a0ab-f0bd-41a3-8f36-248bae3c8e41,
  abstract     = {{<p>Background Although genetic variants associated with bladder cancer (BCa) risk have been identified through hypothesis-driven and genome-wide association studies, a systematic understanding of BCa genetic susceptibility at the gene and pathway levels remains to be achieved. Materials and methods In this 2-stage functional genomics study, we used 5 independent tools for genome-wide gene mapping and ranking based on BCa genome-wide association studies summary statistics, followed by a meta-analysis of gene-level significance p values, to obtain a consensus gene ranking in terms of association with BCa. Subsequently, we performed preranked gene-set enrichment analysis to identify the functional pathways involved in BCa genetic susceptibility. Joint analysis with gene-set enrichment analysis, based on somatic alteration frequency, was performed to explore the pathway-level relationships between genetic susceptibility and somatic alterations in BCa. Results Other than the well-known BCa genes (such as FGFR3, MYC, TERT, CCNE1, and TP63), we additionally prioritized a set of novel genes likely to be genetically implicated in BCa development, including SETD2, a possible tumor suppressor gene involved in chromatin remodeling. We further demonstrated convergence between genetic associations and somatic alterations at both the gene (eg, FGFR3 and TERT) and pathway levels (eg, cell cycle and chromatin modification), as well as functional ontologies specifically implicated in germline predisposition to BCa (eg, CD8/TCR signaling, immune checkpoints, and cytokine signaling). Conclusions We identified several novel genes associated with BCa and demonstrated that genetic variants contribute to the development of BCa by affecting antitumor immunity, response to toxic exposure, and RNA and protein homeostasis and synergizing with somatic alterations in various cancer-related pathways.</p>}},
  author       = {{Shi, Mingjun and Meng, Xiangyu and Xu, Xuan and Wang, Qiaoli}},
  issn         = {{1661-7649}},
  keywords     = {{Bladder cancer; Functional annotation; Genetic susceptibility; Genome-wide association studies; Pathway analysis}},
  language     = {{eng}},
  month        = {{09}},
  number       = {{5}},
  pages        = {{321--330}},
  publisher    = {{Lippincott Williams & Wilkins}},
  series       = {{Current Urology}},
  title        = {{Gene and pathway analysis of genome-wide genetic associations of bladder cancer}},
  url          = {{http://dx.doi.org/10.1097/CU9.0000000000000289}},
  doi          = {{10.1097/CU9.0000000000000289}},
  volume       = {{19}},
  year         = {{2025}},
}